West Pharmaceutical Services, Inc. (WST) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-11 (expected, before the open). EPS estimate 2.27, revenue estimate 825.2M.
Over the last 12 reports the stock moved 10.0% on average (either way), rising 6 times and falling 6. EPS beat estimates 11 of 12 times; revenue 9 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-29 | 2.66 | 2.20 | +20.9% | 874.5M | 827.1M | +2.2% |
| Q2 FY2026 | 2026-07-23 | 2.37 | 2.08 | +13.9% | 872.3M | 840.0M | -8.4% |
| Q1 FY2026 | 2026-04-23 | 2.13 | 1.68 | +26.8% | 844.9M | 780.3M | +11.6% |
| Q4 FY2025 | 2026-02-12 | 2.04 | 1.83 | +11.5% | 805.0M | 794.9M | +1.8% |
| Q3 FY2025 | 2025-10-23 | 1.96 | 1.68 | +16.7% | 804.3M | 785.7M | +7.4% |
| Q2 FY2025 | 2025-07-24 | 1.84 | 1.51 | +21.9% | 766.2M | 726.1M | +15.9% |
| Q1 FY2025 | 2025-04-24 | 1.45 | 1.22 | +18.9% | 698.0M | 713.0M | -1.7% |
| Q4 FY2024 | 2025-02-13 | 1.82 | 1.71 | +6.4% | 748.8M | 740.5M | -33.4% |